Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

Effective as of July 28, 2009 Roy J. Wu has joined Novabay Pharmaceuticals, Inc. as Senior Vice President for Business Development. Wu has more than 30 years of highly successful experience in the pharmaceutical industry with increasingly responsible management positions in global business development, licensing, international marketing, project management, clinical development, and Pacific sector regulatory and pharmaceutical development.

Previously Wu was Vice President of Business Development at Genelabs Technologies Inc., where he was responsible for all business development and licensing activities, including search, evaluation, contract negotiations for all in- and out-license transactions as well as alliance management and assisting in corporate financing activities.

Prior to Genelabs, Wu participated in the 1997 establishment of Kissei Pharma USA Inc., the U.S. subsidiary of Kissei Pharmaceuticals Co. of Japan and served as Vice President of Kissei Pharma USA Inc. for four years. Wu also was Director of Business Development for Quintiles-BRI, a clinical research organization, after working for 16 years at Syntex Corporation.

Wu received his MBA in International Finance from the University of San Francisco, School of Business.

---